Supportive Care and Symptom Management Clinical Trials

Titlesort ascending Intervention NCT ID Sponsor Status
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory... Infliximab, Intravenous Immunoglobulin Therapy, Prednisone, Quality-of-Life Assessment, Questionnaire Administration NCT04438382 ECOG-ACRIN Cancer Research Group Recruiting
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making Usual Care, Web-based decision aid NCT03766009 Alliance for Clinical Trials in Oncology Active, not recruiting
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials Questionnaires NCT05108298 Eastern Cooperative Oncology Group Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors Biospecimen Collection, Questionnaire Administration NCT04871542 Southwest Oncology Group Recruiting
Geriatric Evaluation and Management With Survivorship Health Education (GEMS) for Older Survivors... Best Practice, Comprehensive Geriatric Assessment, Educational Intervention, Exercise Intervention, Questionnaire Administration, Tailored Intervention NCT05006482 University of Rochester NCORP Research Base Not yet recruiting
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Laboratory Biomarker Analysis, Questionnaire Administration NCT00082745 Children's Oncology Group Recruiting
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment Quality-of-Life Assessment, Questionnaire Administration NCT03516942 ECOG-ACRIN Cancer Research Group Active, not recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure... Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration NCT01790152 Children's Oncology Group Recruiting
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Interview, Questionnaire Administration NCT03963739 Wake Forest University Health Sciences Recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III... Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT04137107 Alliance for Clinical Trials in Oncology Recruiting

Pages